JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB142723

Mithramycin A (Plicamycin), DNA and RNA polymerase inhibitor

Be the first to review this product! Submit a review

|

(6 Publications)

MW 1085.1 Da, Purity >98%. DNA and RNA polymerase inhibitor, DNA binding transcriptional inhibitor (Sp1 and Sp3). Shows antineoplastic activity.
1 Images
Chemical Structure - Mithramycin A (Plicamycin), DNA and RNA polymerase inhibitor (AB142723)
  • Chemical Structure

Lab

Chemical Structure - Mithramycin A (Plicamycin), DNA and RNA polymerase inhibitor (AB142723)

2D chemical structure image of ab142723, Mithramycin A (Plicamycin), DNA and RNA polymerase inhibitor

Key facts

CAS number

18378-89-7

Purity

>98%

Form

Solid

form

Molecular weight

1085.1 Da

Molecular formula

C<sub>5</sub><sub>2</sub>H<sub>7</sub><sub>6</sub>O<sub>2</sub><sub>4</sub>

PubChem

163659

Nature

Synthetic

Solubility

Soluble in ethanol to 5 mM

Soluble in DMSO to 10 mM

Biochemical name

Plicamycin

Biological description

DNA and RNA polymerase inhibitor, DNA binding transcriptional inhibitor (Sp1 and Sp3). Shows antineoplastic activity.

Canonical smiles

CC1C(C(CC(O1)OC2CC(OC(C2O)C)OC3=CC4=CC5=C(C(=O)C(C(C5)C(C(=O)C(C(C)O)O)OC)OC6CC(C(C(O6)C)O)OC7CC(C(C(O7)C)O)OC8CC(C(C(O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O

Isomeric smiles

C[C@@H]1[C@H]([C@@H](C[C@@H](O1)O[C@@H]2C[C@@H](O[C@@H]([C@H]2O)C)OC3=CC4=CC5=C(C(=O)[C@H]([C@@H](C5)[C@@H](C(=O)[C@H]([C@@H](C)O)O)OC)O[C@H]6C[C@H]([C@@H]([C@H](O6)C)O)O[C@H]7C[C@H]([C@H]([C@H](O7)C)O)O[C@H]8C[C@]([C@@H]([C@H](O8)C)O)(C)O)C(=C4C(=C3C)O)O)O)O

InChi

InChI=1S/C52H76O24/c1-18-29(72-34-14-30(43(58)21(4)68-34)73-33-13-28(54)42(57)20(3)67-33)12-26-10-25-11-27(49(66-9)48(63)41(56)19(2)53)50(47(62)39(25)46(61)38(26)40(18)55)76-36-16-31(44(59)23(6)70-36)74-35-15-32(45(60)22(5)69-35)75-37-17-52(8,65)51(64)24(7)71-37/h10,12,19-24,27-28,30-37,41-45,49-51,53-61,64-65H,11,13-17H2,1-9H3/t19-,20-,21-,22-,23-,24-,27+,28-,30-,31-,32-,33+,34+,35+,36+,37+,41+,42-,43-,44-,45+,49+,50+,51-,52+/m1/s1

InChiKey

CFCUWKMKBJTWLW-BKHRDMLASA-N

IUPAC Name

(2S,3S)-2-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4-[(2S,4S,5R,6R)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-3-[(1S,3S,4R)-3,4-dihydroxy-1-methoxy-2-oxopentyl]-6-[(2S,4R,5R,6R)-4-[(2S,4R,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-5-hydroxy-6-methyloxan-2-yl]oxy-8,9-dihydroxy-7-methyl-3,4-dihydro-2H-anthracen-1-one

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
The product can be stored for up to 12 months

Need more advice on solubility, usage and handling? Please visit our our product support page for more details.

|

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

|

Refer to SDS for further information.

Product protocols

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Cell reports 42:113288 PubMed37874675

2023

Naringenin improves muscle endurance via activation of the Sp1-ERRγ transcriptional axis.

Applications

Unspecified application

Species

Unspecified reactive species

Zhenyu Lv,Jiao Meng,Sheng Yao,Fu Xiao,Shilong Li,Haoyang Shi,Chen Cui,Kaixian Chen,Xiaomin Luo,Yang Ye,Chang Chen

Biochimica et biophysica acta. Gene regulatory mec 1863:194597 PubMed32603878

2020

Sp4 controls constitutive expression of neuronal serine racemase and NF-E2-related factor-2 mediates its induction by valproic acid.

Applications

Unspecified application

Species

Unspecified reactive species

He Zhang,Jinfang Lu,Shengzhou Wu

Investigative ophthalmology & visual science 61:45 PubMed32572455

2020

VIP Induces Changes in the F-/G-Actin Ratio of Schlemm's Canal Endothelium via LRRK2 Transcriptional Regulation.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoqin Yan,Mu Li,Zhaoxia Luo,Yin Zhao,Hong Zhang,Liwen Chen

Journal of the American Heart Association 9:e014103 PubMed31880978

2019

Drug-Eluting Stent Targeting Sp-1-Attenuated Restenosis by Engaging YAP-Mediated Vascular Smooth Muscle Cell Phenotypic Modulation.

Applications

Unspecified application

Species

Unspecified reactive species

Chen Huang,Jie Zhao,Yuelin Zhu

Oncogene 39:1414-1428 PubMed31659258

2019

The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-α/IL-33/ST2L signaling promotes gastric cancer metastasis.

Applications

Unspecified application

Species

Unspecified reactive species

Quan Zhou,Xiongyan Wu,Xiaofeng Wang,Zhenjia Yu,Tao Pan,Zhen Li,Xinyu Chang,Zhijian Jin,Jianfang Li,Zhenggang Zhu,Bingya Liu,Liping Su

Cytokine 108:24-36 PubMed29558695

2018

Transcription factor specificity protein 1 modulates TGFβ1/Smad signaling to negatively regulate SIGIRR expression by human M1 macrophages stimulated with substance P.

Applications

Unspecified application

Species

Unspecified reactive species

Rui Yamaguchi,Arisa Sakamoto,Reona Yamaguchi,Misa Haraguchi,Shinji Narahara,Hiroyuki Sugiuchi,Yasuo Yamaguchi
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com